Boston Scientific Corporation today announced the close of its acquisition of Axonics, Inc. , a medical technology company focused on the development and commercialization of differentiated devices to ...

The medical device maker has completed more than 40 acquisitions in recent years, helping turn it into one of the state’s ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

Erica Denhoff / Icon Sportswire via Getty Images Boston Scientific ... of its cardiovascular products to $2.73 billion. The MedSurg division, which includes endoscopy, urology, and neuromodulation ...

Boston Scientific BSX is gaining traction in the international markets. New regulatory approvals and accretive acquisitions ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Boston Scientific shares fell ... a 25% sales jump of its cardiovascular products to $2.73 billion. The MedSurg division, which includes endoscopy, urology, and neuromodulation devices, had ...

Boston Scientific's strong history, margins, and pipeline make it a buy despite other analysts' Hold rating, with 15% growth ...

“We’re excited to add this excellent business into Boston Scientific and our Urology business,” said Mike Mahoney, chair and CEO, Boston Scientific. Boston Scientific agreed to pay $3.7 ...